Table 1.
Clinicopathological characteristics of HGSOC patients.
| Clinicopathological Characteristics |
Group A Early, (FIGO I–II) n = 55, (n%) |
Group B Advanced (FIGO III) n = 104, (n%) |
Group C Metastatic (FIGO IV) n = 49, (n%) |
|---|---|---|---|
| Histology | |||
| Serous | 55 (100.0) | 104 (100.0) | 49 (100.0) |
| Tumor grade (G) | |||
| G1 | - | - | - |
| G2 | 4 (7.3) | 22 (21.2) | 4 (8.2) |
| G3 | 51 (100.0) | 82 (78.9) | 45 (91.8) |
| FIGO stage | |||
| I | 14 (25.5) | - | |
| II | 31(56.5) | - | |
| III | - | 104 (100.0) | - |
| IV | - | 49 (100.0) | |
| Age | Median age = 57 | Median age = 66 | Median age = 61 |
| ≥median age | 28 (50.9) | 52 (50.0) | 24 (49.0) |
| <median age | 27 (49.1) | 52 (50.0) | 25 (51.0) |
| Distant metastasis (M) | |||
| M0 | 55 (100.0) | 104 (100.0) | - |
| M1 | - | - | 49 (100.0) |
| Unknown | - | - | - |